Solventum Corporation

As of June 30, 2026, Solventum Corporation carries a market capitalization of 220.00B, placing it among publicly traded companies globally. Its enterprise value stands at 305.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Solventum Corporation's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Solventum Corporation has 170.11M shares outstanding.

As of June 30, 2026, Solventum Corporation trades at a trailing price-to-earnings ratio of 8.98. The price-to-sales ratio is 1.55, and the price-to-book ratio stands at 2.62.

As of June 30, 2026, Solventum Corporation trades at an EV/EBITDA multiple of 6.77 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.10 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 8.42 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Solventum Corporation trades at an EV/FCF ratio of 163.22, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 305.31B versus a market cap of 220.00B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Solventum Corporation maintains a current ratio of 1.02, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 110.15, indicating elevated leverage, while an interest coverage ratio of 9.71 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Solventum Corporation posted a return on equity (ROE) of 33.96, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 16.21 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.78, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 15.40, useful for judging operating efficiency across full business cycles. The company generates approximately 7.08M in revenue per employee across its workforce of 20,500.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.76 indicates how many times Solventum Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Solventum Corporation recorded 4.56B in income tax expense. That works out to an effective tax rate of 15.39, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 29.63B, leaving 25.05B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 10, 2026, Solventum Corporation's stock has gained approximately 7.18% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Solventum Corporation generated 145.17B in revenue and converted that into 25.05B in net income, yielding earnings per share of 143.29. EBITDA reached 45.11B, while operating income came in at 9.17B.

As of June 30, 2026, Solventum Corporation holds 7.04B in cash and equivalents against 92.35B in total debt, resulting in a net debt position of 81.70B. Total book value stands at 83.85B, with working capital of 1.36B providing operational flexibility.

Solventum Corporation produced 3.65B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.71B in capital expenditures, free cash flow totaled -2.06B - equivalent to -11.86 per share.

Over the twelve months ended June 30, 2026, Solventum Corporation posted a gross margin of 54.68, reflecting its pricing power and cost economics. The operating margin of 6.32 and net profit margin of 17.26 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -0.91: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 25.08, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Solventum Corporation shareholders.

As of June 30, 2026, Solventum Corporation has an Altman Z-Score of 2.86, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.